menu search

VLNS / Stifel GMP repeats 'Buy' on The Valens Company on its ability to endure near-term headwinds and reach profitability

Stifel GMP repeats 'Buy' on The Valens Company on its ability to endure near-term headwinds and reach profitability
Stifel GMP has repeated its 'Buy' rating on The Valens Company (TSX:VLNS, OTCQX:VLNCF) with a target price of C$5.25 due to its greater confidence in the company's ability to endure near-term headwinds. In a note to clients, the broker's analysts said they also came away from an investor day more comfortable with Valens' new guidance that it will reach profitability by the fourth quarter of fiscal 2022 and generate $225 million in full-year sales in 2023 at a 10% EBITDA margin. Read More
Posted: Feb 8 2022, 13:27
Author Name: Proactive Investors
Views: 111718

VLNS News  

The Valens Company acquisition wrapped up by Canada's largest private liquor and cannabis retailer SNDL

By Proactive Investors
January 17, 2023

The Valens Company acquisition wrapped up by Canada's largest private liquor and cannabis retailer SNDL

SNDL Inc, the largest private sector liquor and cannabis retailer in Canada, revealed that it has completed the previously disclosed acquisition of al more_horizontal

Why SNDL Stock Flew as High as 5% on Tuesday

By The Motley Fool
January 3, 2023

Why SNDL Stock Flew as High as 5% on Tuesday

An acquisition dating from last summer has finally closed. more_horizontal

The Valens Company says shareholders overwhelmingly vote in favour of takeover by SNDL

By Proactive Investors
November 30, 2022

The Valens Company says shareholders overwhelmingly vote in favour of takeover by SNDL

The Valens Company (TSX:VLNS, OTCQX:VLNCF) announced that its shareholders have voted overwhelmingly in favour of the resolution approving the plan of more_horizontal

The Valens Company receives sales licence amendment from Health Canada for its Pommies manufacturing facility

By Proactive Investors
November 3, 2022

The Valens Company receives sales licence amendment from Health Canada for its Pommies manufacturing facility

The Valens Company (TSX:VLNS, OTCQX:VLNCF) said it has received a sales licence amendment from Health Canada for its Pommies manufacturing facility lo more_horizontal

Does SNDL's Latest Acquisition Make the Stock a Buy?

By The Motley Fool
August 31, 2022

Does SNDL's Latest Acquisition Make the Stock a Buy?

SNDL recently announced plans to acquire Valens. more_horizontal

Don't Rule Out A Bull Market (Podcast Transcript)

By Seeking Alpha
August 2, 2022

Don't Rule Out A Bull Market (Podcast Transcript)

Happy to have Alan Brochstein back! Thoughts on the recent rally (less about Bulls buying than Bears covering), political doubts and overall optimism. more_horizontal

The Valens Company nominates marketing and branding expert Aida Moudachirou-Rebois for election to company's board

By Proactive Investors
July 20, 2022

The Valens Company nominates marketing and branding expert Aida Moudachirou-Rebois for election to company's board

The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc has announced that Aida Moudachirou-Rebois, senior vice-president and global chief marketing officer at more_horizontal

These 7 Cannabis Stocks Just Dropped Smoking Hot News

By Schaeffers Research
July 15, 2022

These 7 Cannabis Stocks Just Dropped Smoking Hot News

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, a more_horizontal


Search within

Pages Search Results: